[Treatment of advanced non-Hodgkin's lymphoma using adriblastin and endoxan as well as ixoten].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male
D000970:Antineoplastic Agents; D004317:Doxorubicin; D003520:Cyclophosphamide; C003726:trofosfamide
Behandlung fortgeschrittener Non-Hodgkin-Lymphome mit Abriblastin und Endoxan bzw. Ixoten.